原蛋白对乳腺癌中多克索鲁比有效性的调节
Aleksandra Golonko1, Adam Jan Olichwier1, Agata Szklaruk1
1Clinical Research Centre, Medical University of Bialystok, 15-089 Bialystok, Poland.
Molecules (Basel, Switzerland)
|June 19, 2024
概括
原蛋白是一种类黄,通过降低乳腺癌细胞活力和迁移来表现出抗癌作用. 它与多克索鲁比的协同效应可能涉及ATP结合盒载体,而不是脂质代谢.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 作为一种天然的黄类化合物,apigenin被认为具有潜在的治疗用途,特别是在癌症治疗中.
- 它的抗癌机制除了其有限的抗氧化特性之外,还在探索.
研究的目的:
- 研究阿皮基宁对乳腺癌细胞活力和迁移的影响.
- 了解阿皮基宁与化学疗法药物多克索鲁比辛在癌细胞中的相互作用.
主要方法:
- 在对雌激素依赖的 (MCF-7) 和非雌激素依赖的 (MDA-MB-231) 乳腺癌细胞系上测试了阿皮基宁的影响.
- 观察了脂质滴滴积累,并进行了化学信息学分析.
主要成果:
- 原蛋白在两个细胞系上都表现出剂量依赖的细胞毒性和抗迁移作用.
- 原素和多克索鲁素都诱导了MDA-MB-231细胞中的脂质滴积累,但不是MCF-7细胞中的脂质滴积累,也不是一起使用时的脂质滴积累.
- 化学信息学表明与ATP结合盒载体的相互作用以及对AKT和MYC通路的潜在间接影响.
结论:
- 原蛋白通过独立于直接抗氧化活性的机制调节癌细胞动态.
- 了解原蛋白与化疗药物的相互作用对于开发有效的辅助疗法至关重要.
- 基于黄类的辅助疗法在癌症管理中显示出有前途.
相关概念视频
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K